Catherine Patte
Institut Gustave Roussy
Pediatric Department
Villejuif
France
Name/email consistency: high
- Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K., Cairo, M.S. Blood (2007)
- Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. Patte, C., Laplanche, A., Bertozzi, A.I., Baruchel, A., Frappaz, D., Schmitt, C., Mechinaud, F., Nelken, B., Boutard, P., Michon, J. J. Clin. Oncol. (2002)
- Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol. Patte, C., Sakiroglu, C., Ansoborlo, S., Baruchel, A., Plouvier, E., Pacquement, H., Babin-Boilletot, A. Ann. Oncol. (2002)
- Treatment of mature B-ALL and high grade B-NHL in children. Patte, C. Best. Pract. Res. Clin. Haematol (2002)
- The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G., Frappaz, D., Lutz, P., Coze, C., Perel, Y., Raphaël, M., Terrier-Lacombe, M.J. Blood (2001)
